Mid Wynd International Investment Trust Regulatory News (MWY)

MID WYND INTERNATIONAL INVESTMENT TRUST PLC (the 'Company')

LEI: 549300D32517C2M3A561

Appointment of independent non-executive Director

The Board of Directors of the Company is pleased to announce the appointment of Mrs Diana Dyer Bartlett as an independent non-executive Director of the Company with effect from 1 February 2020.

After qualifying as a chartered accountant with Deloitte Haskins & Sells, Diana spent five years in investment banking with Hill Samuel Bank. Since then she has held a number of roles as finance director of various venture capital and private equity backed businesses and listed companies involved in software, financial services, renewable energy and coal mining. She was also company secretary of Tullett Prebon plc and Collins Stewart Tullett plc.

Diana is currently a non-executive director and Audit Committee Chairman of Smithson Investment Trust plc and SmartSpace Software plc and a non-executive director of Rutherford Health plc.

During her appointment as a director of SmartSpace Software plc (formerly known as Coms plc and RedstoneConnect plc), the Coms plc group had trading difficulties and Diana took on an interim role as chief finance officer. Following the departure of the finance director and chief executive officer of Coms plc, Diana became a director of the majority of Coms plc's subsidiaries on 1 March 2015. After the sale of the business and assets of most of the Coms plc's subsidiaries, which comprised its telecommunications division, at the end of May 2015 and the discharge of agreed trading liabilities, the following companies were put into creditors' voluntary liquidation: Coms Carrier Services Limited, Network Resource Limited, CloudXL Networks Limited, Coms Mobile Limited, System Online Limited, CloudXL Support Limited, Network Resource Group Limited, Smarter Mobile UK Limited, Coms.com Limited, Premium O Limited, and CloudXL Limited.

Diana resigned from her role as a director of Precious Cells International Limited and its subsidiary, Pharmacells Limited on 31 May 2017. The companies were placed into administration on 28 March 2018 and 13 April 2018 respectively.

There are no other details to be disclosed under paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

For further information, please contact:

Artemis Fund Managers LimitedCompany SecretaryTelephone: 0131 225 7300